1. Home
  2. PRTG

as 07-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Energy

Oil & Gas Production

Nasdaq

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.

Founded: 1973 Country:
VG
Employees: N/A City: N/A
Market Cap: 5.2M IPO Year: N/A
Target Price: $11.00 AVG Volume (30 days): 1.5M
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -8.34 EPS Growth: N/A
52 Week Low/High: $0.13 - $3.60 Next Earning Date: 08-28-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

PRTG Daily Stock ML Predictions

Share on Social Networks: